Archives des Quantitatif - Page 3 sur 3

Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada

Vakili F, Høj SB, Minoyan N, Udhesister S, Laferrière VM, Bruneau J, Larney S. Drug Alcohol Rev. 2025 Apr 2. doi: 10.1111/dar.14050. Epub ahead of print. PMID: 40171634.

Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada Lire la suite »

Young adult drinking during the COVID-19 pandemic: Examining the role of anxiety sensitivity, perceived stress, and drinking motives

Publications / ICRIS Québec

Corran C, Norman P, O’Connor RM. J Am Coll Health. 2025 Jan 6:1-9. doi: 10.1080/07448481.2024.2440761. Epub ahead of print. PMID: 39761074

Young adult drinking during the COVID-19 pandemic: Examining the role of anxiety sensitivity, perceived stress, and drinking motives Lire la suite »

Illicit drug toxicity from opioid, stimulant or sedative use in adolescents: results of a Canadian one-time cross-sectional study

Publications / ICRIS Québec

Carwana M, Moore E, Shariati H, Samji H, Chadi N. Paediatr Child Health. 2025 Apr 1;30(4):320-326. doi: 10.1093/pch/pxae104. PMID: 40756552; PMCID: PMC12316521

Illicit drug toxicity from opioid, stimulant or sedative use in adolescents: results of a Canadian one-time cross-sectional study Lire la suite »

Predicting Fatal Drug Poisoning Among People Living with HIV-HCV Co-Infection

Publications / ICRIS Québec

Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B. Klein Can Liver J. 2025 Mar 12;8(2):295-308. doi: 10.3138/canlivj-2024-0060. PMID: 40677990; PMCID: PMC12269253.

Predicting Fatal Drug Poisoning Among People Living with HIV-HCV Co-Infection Lire la suite »

An Approach to Providing Timely Mental Health Services to Diverse Youth Populations

Publications / ICRIS Québec

Srividya N. Iyer, Parminder Boksa, R. Joober, J. Shah, R. Fuhrer, N. Andersson, S. Lal, et coll. JAMA Psychiatry. 2025 Feb 26:e244880. doi: 10.1001/jamapsychiatry.2024.4880. Epub ahead of print. PMID: 40009399; PMCID: PMC11866065. CONSULTER

An Approach to Providing Timely Mental Health Services to Diverse Youth Populations Lire la suite »

Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada

Publications / ICRIS Québec

Mariam Z. El Sheikh, Jim Young, Dimitra Panagiotoglou, Curtis Cooper, Joseph Cox, Valérie Martel‑Laferrière, Sharon Walmsley, Marina B. Klein Can Liver J. 2025 Feb 25;8(1):49-62. doi: 10.3138/canlivj-2024-0042. PMID: 40678661; PMCID: PMC12269190.

Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada Lire la suite »

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Publications / ICRIS Québec

Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D. Harm Reduct J. 2025 Feb 8;22(1):14. doi: 10.1186/s12954-025-01157-4. PMID: 39923043; PMCID: PMC11806552.

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study Lire la suite »

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022

Publications / ICRIS Québec

Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Martin NK, Hyshka E, Larney S. Int J Drug Policy. 2025 Mar;137:104711. doi: 10.1016/j.drugpo.2025.104711. Epub 2025 Jan 21. PMID: 39842392

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022 Lire la suite »

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial

Publications / ICRIS Québec

Conrod P, Stewart SH, Seguin J, Pihl R, Masse B, Spinney S, Lynch S. Am J Psychiatry. 2025 Jan 15:appiajp20240042. doi: 10.1176/appi.ajp.20240042. Epub ahead of print. PMID: 39810554

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial Lire la suite »

The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021

Publications / ICRIS Québec

Popovic N, Yang Q, Campeau L, Elliott J, Williams A, Lima VD, Sereda P, Cox J. Can Commun Dis Rep. 2025 Jan 2;51(1):35-42. doi: 10.14745/ccdr.v51i01a05. PMID: 39781235; PMCID: PMC11709143 CONSULTER

The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021 Lire la suite »

Quantitatif

Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada

Young adult drinking during the COVID-19 pandemic: Examining the role of anxiety sensitivity, perceived stress, and drinking motives

Illicit drug toxicity from opioid, stimulant or sedative use in adolescents: results of a Canadian one-time cross-sectional study

Predicting Fatal Drug Poisoning Among People Living with HIV-HCV Co-Infection

An Approach to Providing Timely Mental Health Services to Diverse Youth Populations

Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022

Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial

The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021

MENU

CONTACT

Centre de Recherche du CHUM

Téléphone

Courriel